The animal health division of Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced plans to close a Vigo County operation. Our partners at WTHI-TV report the company says the nearly two dozen workers in Terre Haute have been offered similar positions and pay at a larger facility in Clinton. Lilly spokesman Ed Sagebiel says the decision is not based on performance.

Operations are set to cease in Terre Haute in 2016.

WTHI reports the company is looking to consolidate work at the Terre Haute Elanco plant into another facility.

The Clinton plant employs approximately 500.

August 13, 2014

Statement From Eli Lilly and Co. Spokesman Ed Sagebiel

Elanco has made the decision to discontinue enzyme production at our Terre Haute, Indiana, site. The site, which Elanco acquired from ChemGen in 2012, manufactures enzymes that are added to food-animal feed mixtures to help animals digest food. The site closure is not expected to take effect until early 2016.

This decision was not influenced by the Terre Haute site's performance, which has been improving significantly since the acquisition. Rather, the decision is driven by the need to consolidate our global enzyme manufacturing network to create a single enzyme-production site, which will reduce complexities.

Importantly, we will offer the 23 Lilly employees at the Terre Haute site a position at our nearby Clinton site, which manufactures products for Elanco. The employees at our Terre Haute site have technical skills and backgrounds that are very transferrable to our broader Lilly manufacturing organization.

We will also offer severance, based on years of service, for employees who do not wish to pursue a role at Clinton.

As always, our priority will continue to be reliable supply of safe, high-quality products to customers, and support for affected employees.

Sources: WTHI-TV, Eli Lilly and Co.

Story Continues Below